IL17A and Miyoshi myopathy: DCs can also indirectly enhance osteoclastogenesis by promoting the expansion of T helper 17 (Th-17) clones in MM microenvironment (62) and the consequent accumulation of IL-17, known to be a potent pro-osteoclastogenic factor, in MM BM (60).